The NLRP3 inflammasome as a target for sensorineural hearing loss

被引：9
|
作者：
Gregory, Grace E. [1 ,2 ,3 ]
Munro, Kevin J. [4 ,5 ]
Couper, Kevin N. [2 ,3 ]
Pathmanaban, Omar N. [1 ,2 ,3 ,6 ]
Brough, David [1 ,2 ,3 ]
机构：
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Neurosci,Manchester Acad Hlth Sci Ctr, Manchester, England
[2] Univ Manchester, Geoffrey Jefferson Brain Res Ctr, Manchester Acad Hlth Sci Ctr, Northern Care Alliance NHS Grp, Manchester, England
[3] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester, England
[4] Univ Manchester, Manchester Ctr Audiol & Deafness, Sch Hlth Sci, Manchester, England
[5] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, England
[6] Salford Royal Hosp NHS Fdn Trust, Manchester Ctr Clin Neurosci, Dept Neurosurg, Salford, England
来源：
CLINICAL IMMUNOLOGY | 2023年 / 249卷
基金：
英国医学研究理事会;
关键词：
Sensorineural hearing loss; Inflammation; Cochlea; NLRP3; inflammasome; Interleukin-1;
D O I：
10.1016/j.clim.2023.109287
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Sensorineural hearing loss is the most common type of hearing loss in adults and occurs due to damage of the inner ear caused by a range of factors including ageing, excessive noise, toxins, and cancer. Auto-inflammatory disease is also a cause of hearing loss and there is evidence that inflammation could contribute to hearing loss in other conditions. Within the inner ear there are resident macrophage cells that respond to insults and whose activation correlates with damage. The NLRP3 inflammasome is a multi-molecular pro-inflammatory protein complex that forms in activated macrophages and may contribute to hearing loss. The aim of this article is to discuss the evidence for the NLRP3 inflammasome and associated cytokines as potential therapeutic targets for sensorineural hearing loss in conditions ranging from auto-inflammatory disease to tumour-induced hearing loss in vestibular schwannoma.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Inhibiting the NLRP3 Inflammasome
    El-Sharkawy, Lina Y.
    Brough, David
    Freeman, Sally
    MOLECULES, 2020, 25 (23):
  • [32] Cardiolipin and the Nlrp3 Inflammasome
    O'Neill, Luke A. J.
    CELL METABOLISM, 2013, 18 (05) : 610 - 612
  • [33] The NLRP3 inflammasome and stroke
    Tong, Yeqing
    Ding, Zhi-Hong
    Zhan, Fa-Xian
    Cai, Li
    Yin, Xiaoxv
    Ling, Jin-Lian
    Ye, Jian-Jun
    Hou, Shuang-Yi
    Lu, Zuxun
    Wang, Zhi-Hong
    Liu, Jia-Fa
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 4787 - 4794
  • [34] Knocking In the NLRP3 Inflammasome
    Girardin, Stephen E.
    IMMUNITY, 2009, 30 (06) : 761 - 763
  • [35] NLRP3 inflammasome in sepsis
    Shi, Xueyan
    Tan, Sichuang
    Tan, Sipin
    MOLECULAR MEDICINE REPORTS, 2021, 24 (01)
  • [36] Vasculitis and the NLRP3 inflammasome
    Hamzaoui, Kamel
    Hamzaoui, Agnes
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (01) : 9 - 15
  • [37] Regulation of the NLRP3 inflammasome
    Groslambert, Marine
    Py, Benedicte F.
    M S-MEDECINE SCIENCES, 2018, 34 (01): : 47 - 53
  • [38] Inhibition of the NLRP3 inflammasome attenuates spiral ganglion neuron degeneration in aminoglycoside-induced hearing loss
    Jia Fang
    Zhuangzhuang Li
    Pengjun Wang
    Xiaoxu Zhang
    Song Mao
    Yini Li
    Dongzhen Yu
    Xiaoyan Li
    Yazhi Xing
    Haibo Shi
    Shankai Yin
    Neural Regeneration Research, 2025, 20 (10) : 3025 - 3039
  • [39] Targeting the NLRP3 inflammasome in cochlear macrophages protects against hearing loss in chronic suppurative otitis media
    Schiel, Viktoria
    Bhattacharya, Ritwija
    Gupta, Ankur
    Eftekharian, Kourosh
    Xia, Anping
    Santa Maria, Peter L.
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
  • [40] The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury
    Saifudeen Ismael
    Heba A.Ahmed
    Tusita Adris
    Kehkashan Parveen
    Parth Thakor
    Tauheed Ishrat
    Neural Regeneration Research, 2021, 16 (01) : 49 - 57
12345